Tuesday, November 22, 2022 7:54:11 AM
~~~ World Premiere ~~~ (1:08:21)
by Stew Peters Network November 21, 2022
Why do we never believe them? For centuries, the global elite have broadcast their intentions to depopulate the world - even to the point of carving them into stone. And yet… we never seem to believe them.
The Stew Peters Network is proud to present DIED SUDDENLY, from the award winning filmmakers, Matthew Skow and Nicholas Stumphauzer.
They are the minds behind WATCH THE WATER and THESE LITTLE ONES, and now have a damning presentation on the truth about the greatest ongoing mass genocide in human history.
This documentary was made possible by Goldco. Protect your wealth by investing in precious metals, and use THIS link to receive up to $10,000 in free silver for qualified accounts: https://link.goldco.com/DiedSuddenly
Chris Edwards (Chief Justice of Nuremberg 2.0)
World Premiere: #DiedSuddenly Trending #1 on Twitter
https://twitter.com/diedsuddenly_/ (MIRRORS)
https://beforeitsnews.com/prophecy/2022/11/stew-peters-world-premier-died-suddenly-november-21-2022-2535862.html
https://bitchute.com/video/f0uQP14hW5Ur/ https://rumble.com/v1wac7i-world-premier-died-suddenly.html https://odysee.com/@QuantumRhino:9/Died-Suddenly-(2022):2b
You did it folks! #DiedSuddenly trending #1 globally in entertainment on Twitter. Passing 1M views in the last 3 hours at the below mirror sites. Purebloods rising, we shall change the world! Share the video with as many of your friends and family as you can.
You did it folks! #DiedSuddenly trending #1 globally in entertainment. Purebloods rising, we shall change the world! Share the video with as many of your friends and family as you can. Its time to kill the💉once and for all pic.twitter.com/I1rvirX4tz
— Died Suddenly (@DiedSuddenly_) November 21, 2022
Recent MRNA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:24:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:21:25 PM
- Moderna agrees up to $2.25 billion settlement in COVID vaccine patent dispute • IH Market News • 03/04/2026 11:24:49 AM
- Moderna Resolves Global Patent Litigation with Arbutus/Genevant • ACCESS Newswire • 03/03/2026 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:14:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:10:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:04:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2026 02:56:47 PM
- European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19 • ACCESS Newswire • 02/27/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2026 09:49:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2026 03:26:22 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/20/2026 09:03:07 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2026 09:02:04 PM
- Moderna to Present at Upcoming Conferences in March 2026 • ACCESS Newswire • 02/19/2026 12:00:00 PM
- Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission • ACCESS Newswire • 02/18/2026 12:00:00 PM
- Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE • ACCESS Newswire • 02/17/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:41:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:33:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 12:02:14 PM
- Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates • ACCESS Newswire • 02/13/2026 12:00:00 PM
- Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010 • ACCESS Newswire • 02/10/2026 11:00:00 PM
- Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico • ACCESS Newswire • 02/10/2026 12:00:00 PM
- The $71 Billion Cancer Shift: Why The FDA Is Speeding Up • GlobeNewswire Inc. • 02/05/2026 02:26:03 PM
- Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc. • GlobeNewswire Inc. • 02/04/2026 02:15:00 PM
- Dr. David Berman to Join Moderna as Chief Development Officer • ACCESS Newswire • 01/30/2026 12:30:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM


